Arnaud Fekkar

Centre National de la Recherche Scientifique

Also affiliated with Inserm, Sorbonne Université, Centre d'Immunologie et des Maladies Infectieuses, Centre de Recherche Saint-Antoine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies”.

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

Research Square(2022)10.21203/rs.3.rs-1225906/v1

N/A

0.483DataRank · unranked

24 citations

Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot +95 more

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2200413119

N/A

0DataRank · unranked

196 citations

Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot +95 more

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Science Immunology(2022)10.1126/sciimmunol.abp8966

N/A

0DataRank · unranked

77 citations

Sara E. Vazquez, Jamin Liu, Matthew T. Laurie, Chung‐Yu Wang, Adrian Gervais +95 more

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Science Immunology(2021)10.1126/sciimmunol.abl4340

N/A

0DataRank · unranked

634 citations

Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry +95 more

Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia

Journal of Clinical Immunology(2023)10.1007/s10875-023-01512-9

N/A

0DataRank · unranked

34 citations

Arnaud Fekkar, Adrian Gervais, Tom Le Voyer, L.S. Boers, Clément Conil +60 more

Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia

Journal of Interferon & Cytokine Research(2023)10.1089/jir.2023.0003

N/A

0DataRank · unranked

29 citations

Karita Särekannu, Arnaud Fekkar, Sofie E. Jørgensen, Liis Haljasmägi, Anne Kallaste +18 more

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases

The Journal of Experimental Medicine(2024)10.1084/jem.20231152

N/A

0DataRank · unranked

17 citations

Tom Le Voyer, Xian Liu, Adrian Gervais, Laura Polivka, Axel Cederholm +94 more